Kezar Life Sciences Inc logo

Kezar Life Sciences Inc

NAS:KZR (USA)  
$ 0.82 +0.0335 (+4.28%) 10:08 PM EST
At Loss
P/B:
0.32
Market Cap:
$ 59.45M
Enterprise V:
$ -125.43M
Volume:
443.55K
Avg Vol (2M):
898.98K
Also Trade In:
Volume:
443.55K
At Loss
Avg Vol (2M):
898.98K

Business Description

Description
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.
Name Current Vs Industry Vs History
Cash-To-Debt 10.64
Equity-to-Asset 0.85
Debt-to-Equity 0.1
Debt-to-EBITDA -0.19
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -1.64
Distress
Grey
Safe
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 46.43
9-Day RSI 43.73
14-Day RSI 43.48
6-1 Month Momentum % -16.98
12-1 Month Momentum % -64.8

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 11.66
Quick Ratio 11.66
Cash Ratio 11.35
Days Sales Outstanding 365

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -16.2
Shareholder Yield % -7.63

Profitability Rank

Name Current Vs Industry Vs History
Operating Margin % -1503.39
Net Margin % -1455.29
FCF Margin % -1192.21
ROE % -43.98
ROA % -38.65
ROIC % -465.72
ROC (Joel Greenblatt) % -805.94
ROCE % -40.29